Superbugs: An Emergency of Our Own Making
Kevin Outterson is quoted.
January 27, 2026 Vision‘A Time of Urgency’: Crisis in the Antibacterial Pipeline
Kevin Outterson is quoted.
November 26, 2025 HealioPaying for Prevention: How to Fix AMR’s Broken Incentives
Kevin Outterson is interviewed.
November 20, 2025 Infection Control TodaySeres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155
Kevin Outterson is quoted.
October 29, 2025 World Healthcare ReportWHO Reports 40 Percent Jump in Antibiotic-Resistant infections; BU-Based Nonprofit Leads the Fight Back
Kevin Outterson is interviewed.
October 24, 2025 The Brink‘I fear we are sitting on a time bomb.’ Scientists debate mass distribution of antibiotics in Africa
Kevin Outterson is quoted.
October 21, 2025 ScienceCARB-X Releases 2024 Annual Report Celebrating a Year of Progress
Kevin Outterson is quoted.
April 30, 2025 CARB-XAntimicrobial Resistance: Q&A with Carb-X About the Fight Against AMR
Kevin Outterson is interviewed.
April 15, 2025 European Biotechnology Life and Science Industry MagazineCharting the Path to Tackle Amr: How to Create an Inclusive and Impactful Independent Panel
Kevin Outterson pens an opinion.
January 22, 2025 Center For Global DevelopmentThe Superbug Fight Needs a Better Business Model
Kevin Outterson is quoted.
November 19, 2024 Global Health Now